These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7476296)

  • 1. Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus).
    Cincotta AH; Meier AH
    Metabolism; 1995 Oct; 44(10):1349-55. PubMed ID: 7476296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus.
    Cincotta AH; Schiller BC; Meier AH
    Metabolism; 1991 Jun; 40(6):639-44. PubMed ID: 1865827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster.
    Luo S; Luo J; Cincotta AH
    Chronobiol Int; 2000 Mar; 17(2):155-72. PubMed ID: 10757461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine redirects metabolism and prevents seasonal onset of obese hyperinsulinemic state in Syrian hamsters.
    Cincotta AH; MacEachern TA; Meier AH
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E285-93. PubMed ID: 8447396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters.
    Luo S; Liang Y; Cincotta AH
    Neuroendocrinology; 1999 Mar; 69(3):160-6. PubMed ID: 10087448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
    Kok P; Roelfsema F; Frölich M; van Pelt J; Stokkel MP; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1038-43. PubMed ID: 16803851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor.
    Framnes-DeBoer SN; Bakke E; Yalamanchili S; Peterson H; Sandoval DA; Seeley RJ; Arble DM
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E62-E71. PubMed ID: 31794265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
    Kamath V; Jones CN; Yip JC; Varasteh BB; Cincotta AH; Reaven GM; Chen YD
    Diabetes Care; 1997 Nov; 20(11):1697-701. PubMed ID: 9353611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters.
    Luo S; Meier AH; Cincotta AH
    Neuroendocrinology; 1998 Jul; 68(1):1-10. PubMed ID: 9695933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal and insulin-regulated free fatty acid and glucose metabolism in humans.
    Shadid S; Kanaley JA; Sheehan MT; Jensen MD
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1770-4. PubMed ID: 17299081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One day of overfeeding impairs nocturnal glucose but not fatty acid homeostasis in overweight men.
    Magkos F; Smith GI; Reeds DN; Okunade A; Patterson BW; Mittendorfer B
    Obesity (Silver Spring); 2014 Feb; 22(2):435-40. PubMed ID: 23836730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus).
    Cincotta AH; Wilson JM; deSouza CJ; Meier AH
    J Endocrinol; 1989 Mar; 120(3):385-91. PubMed ID: 2647890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
    Ezrokhi M; Zhang Y; Luo S; Cincotta AH
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
    Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat metabolism in human obesity.
    Campbell PJ; Carlson MG; Nurjhan N
    Am J Physiol; 1994 Apr; 266(4 Pt 1):E600-5. PubMed ID: 8178981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on mechanisms of hepatic insulin resistance in cafeteria-fed rats.
    Davidson MB; Garvey D
    Am J Physiol; 1993 Jan; 264(1 Pt 1):E18-23. PubMed ID: 8430783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons.
    Lillioja S; Foley J; Bogardus C; Mott D; Howard BV
    Metabolism; 1986 Jun; 35(6):505-14. PubMed ID: 3713512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
    Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
    Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation in insulin sensitivity of glucose metabolism is associated with diurnal variations in whole-body and cellular fatty acid metabolism in metabolically normal women.
    Yoshino J; Almeda-Valdes P; Patterson BW; Okunade AL; Imai S; Mittendorfer B; Klein S
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1666-70. PubMed ID: 24878055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.